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Abstract
Background:
The major aim of this study is to evaluate the research productivity of Pakistan Journal of
Pharmaceutical Sciences (PJPS) from 2005 to 2020. For the purpose, bibliometric analysis was
performed.
Methodology:
From March to April 2021, the data was retrieved from Scopus, one of the largest databases in the
world. journal. Later it was analyzed by MS Excel. Based on the Scopus database, this is the 1st
bibliometric report about PJPS.
Results:
From 2005 to 2020, PJPS published 3301 articles. The per year publication and citation details
are provided. In all publications (n=3301), 8066 authors, 6018 institutes or departments and 72 countries
have contributed. Based on the number of publications, citations, and citations per documents (CPD),
details about the top author, institute and country are provided. Infact, from 2005 to 2020, based on the
number of publications University of Karachi and Pakistan topped the list (for each year). By Vosviewer
analysis, we described the collaboration or co-authorship pattern for top author, university, and country.
We also identified and analyzed the 100 most-cited articles in PJPS. Infact the detail co-words analysis of
all 3301 research titles were performed. Total 9288 words were recorded. After co-words analysis it was
found that various drugs and plants were tested in different pathological models. Their efficacy and
mechanism of action were briefly discussed.
Conclusion: The citescore data for the last ten years are described. This suggests that PJPS holds a
credible position in world ranking.
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1.0

Introduction and Literature Review
In 1988, The Journal of Pharmaceutical Sciences (PJPS) was launched by Faculty of Pharmacy,

University of Karachi, Sindh, Pakistan. Initially it was a biannual journal, while its frequency changed as
quarterly in 2005 and bi-monthly in 2013. PJPS is indexed in various global databases i.e. ASCI
Database, AsiaNet, CAB Abstracts, CABI, Chemical Abstracts, EBSCO, EMBASE, EMRmedex, ESSCI,
EVISA, GDPBM, MEDLINE/PubMed, SCImago, SCOPUS, Scribd, WebStatDomain and WorldCat, to
name a few. PJPS publishes original research articles and reviews from all fields of pharmaceutical
sciences.
Bibliometric analysis is commonly used to analyze and monitor the published scientific literature.
It also helps to investigate the flow of knowledge, the growth in literature, and determine the future
direction in different domains. Different bibliometric parameters can be used to measure the impact and
popularity of a specific author, institute, country, or a specific journal (1-3). The present project is
designed to perform the bibliometric analysis of PJPS.
Its worthy to note that Ishtiaq Ahmed et al., reported a 10-Year Bibliometric Study of PJPS from
2006 to 2015. While, Zameer Hussain Baladi reported bibiometric analysis of PJPS from 1998 to 2012
(4,5). However, in both studies the data was collected from the PJPS website (http://www.pjps.pk/).
Scopus is covering PJPS since 2005. This motivated us and the present project is designed to perform the
1st (based on Scopus data) comprehensive bibliometric analysis of PJPS. The manuscript is divided in
several sections.
1. In 1st section brief details about per year publications and citations are provided. Numerical
details about all authors, institutes and countries are also provided. Infact, based on the number of
publications, citations and citations per document, the top authors, institutes, and countries are
described.
2. In 2nd section, the co-authorship network,
3. In 3rd section, details about the top 100 most cited documents,
4. In 4th section, the co-words analysis for all publications and
5. In 5th and last section, the journal metrics are described.

2.0

Material and Method

2.1

Scopus and VOSVeiwer Analysis
The data was retrieved from the Scopus database on 1st April 2021 using the name of the journal

(PJPS). All published documents were analyzed for access type, year, author name, document type, key
words, affiliations, and country. Later the results were exported in CSV format for further analysis. The
publications were analyzed on VOSviewer. The software was developed by Van Eck and Waltman (2010)
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for constructing and visualizing bibliometric networks. For more information, please see
http://www.vosviewer.com/. We selected co-authorship, co-occurrence of words and citations for detail
analysis.

3.0

Results and Discussion

3.1

Section-One: Analysis of publication outputs
Since 2005 to 2020, PJPS has completed research publications of 3297 documents, majorly

comprising of articles (n=3183), reviews (n=109), notes (n=2), short surveys (n=2) and conference papers
(n=1). For detail analysis we only focused on articles and reviews (n=3301). Nine (n=9) documents from
the year 1995 are also included in the list. The highest documents are published in the year 2018 (n=431),
followed by 2019 (n=401), 2017 (n=351), 2016 (n=338) and 2015 (n=335). The per year publications are
described in figure 1. PJPS received total 17056 citations. The highest citations were recorded for the year
2020 (n=2759), followed by 2019 (n=2194), 2018 (n=2089), 2017 (n=1962) and 2016 (n=1722) as shown
in figure 1.
In all publications (n=3301), 8066 authors, 6018 institutes or departments and 72 countries have
contributed. For numerical representation, we designed the publication (table 1) and citations clubs (table
2). For example, ten authors have published between forty and fifty documents. Similarly, fourteen
departments have contributed in twenty to twenty-nine publications. Furthermore, details about each
author (supp table 1), institutes (supp table 2) and country (supp table 3) are also provided.
Based on the number of publications the top ten authors are Ahmad M. (n=59), Arayne M.S.
(n=47), Sultana N. (n=47), Wang Y. (n=46), Haleem D.J. (n=45), Ahmad S. (n=44), Ahmed S. (n=44),
Ali M. (n=44), Usmanghani K. (n=44) and Khan M.A. (n=44). Institutionally, the highest documents are
published by Department Of Chemistry, Government College University, Lahore, Pakistan (n=47),
followed by Department Of Pharmacology, Faculty Of Pharmacy And Pharmaceutical Sciences,
University Of Karachi, Karachi, Pakistan (n=42), Department Of Pharmaceutics, Faculty Of Pharmacy
And Pharmaceutical Sciences, University Of Karachi, Karachi, Pakistan (n=41), Institute Of Molecular
Biology And Biotechnology, Bahauddin Zakariya University, Multan, Pakistan (n=29), Department Of
Chemistry, Government College University, Faisalabad, Pakistan (n=29), Department Of Chemistry,
University Of Karachi, Karachi, Pakistan (n=28), Department Of Pharmaceutics, Faculty Of Pharmacy,
University Of Karachi, Karachi, Pakistan (n=27), University College Of Pharmacy, University Of The
Punjab, Lahore, Pakistan (n=26), Department Of Chemistry, University Of Karachi, Karachi-75270,
Pakistan (n=24) and Neurochemistry And Biochemical Neuropharmacology Research Unit, Department
Of Biochemistry, University Of Karachi, Karachi, Pakistan (n=24). While, Pakistan (n=1619), published
the highest number of documents in PJPS, followed by China (n=812), India (n=199), Saudi Arabia
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(n=190), Malaysia (n=134), Egypt (n=124), Iran (n=99), Nigeria (n=69), Turkey (n=60) and Bangladesh
(n=50).
Citation analysis is considered an invaluable technique for literature review. Furthermore, it also makes it
possible to recognize information from previous research and provides clues for the subject’s
development which could be a possible indicator in research pattern (6,7).
Based on citations, the top ten authors are Arayne M.S. (n=592), Sultana N. (n=587), Shoaib
M.H. (n=429), Ahmad M. (n=330), Yousuf R.I. (n=329), Haleem D.J. (n=325), Qadir M.I. (n=286),
Ahmed M. (n=285), Bakht J. (n=272) and Khan R.A. (n=266). Institutionally the highest citations were
recorded for Similarly, the top ten universities or organizations are United States Environmental
Protection Agency (n= 68), The Dow Chemical Company (n= 41), National Institute for Public Health
and the Environment (n= 37), Gradient Corporation (n= 30), Imperial College London (n= 29), University
of Massachusetts Amherst (n= 28), DuPont (n= 27), University of Nebraska Medical Center (n= 27),
National Institute of Environmental Health Sciences NIEHS (n= 25) and ILSI Health and Environmental
Sciences Institute (n= 24). While, based on citations, the top ten countries are Pakistan (n=7711), India
(n=2136), China (n=1813), Iran (n=1506), Saudi Arabia (n=904), Egypt (n=871), Malaysia (n=689),
Turkey (n=605), Bangladesh (n=508) and Nigeria (n=490).
We also calculated citations per documents (CPD) for those authors, institutes and countries
which have published atleast five publications. The top ten authors in this series are Israili Z.H. (n=33),
Lyoussi B. (n=33), Abo-Salem O.M. (n=24), Nwafor P.A. (n=21), Okokon J.E. (n=21), Ali M.S. (n=20),
Bachar S.C. (n=20), Zia-ul-Haq M. (n=19), Azhar I.(n=17) and Ansari A. (n=15). Institutionally the
highest CPD was noted for Department Of Pharmaceutics, Faculty Of Pharmacy, University Of Karachi,
Karachi-75270, Pakistan (n=45), followed by Department Of Microbiology, University Of Karachi,
Karachi-75270, Pakistan (n=26), Department Of Pharmacology, Faculty Of Pharmacy, University Of
Karachi, Pakistan (n=24), School Of Materials Science And Engineering, Central South University Of
Forestry And Technology, Changsha, China (n=18), Department Of Chemistry, University Of Karachi,
Karachi-75270, Pakistan (n=17), Department Of Pharmaceutical Technology, University Of Dhaka,
Dhaka-1000, Bangladesh (n=14), Department Of Chemistry And Biochemistry, University Of
Agriculture, Faisalabad, Pakistan (n=13), Faculty Of Pharmacy, Bahauddin Zakariya University, Multan,
Pakistan (n=13), Department Of Pharmaceutical Chemistry, Research Institute Of Pharmaceutical
Sciences, Faculty Of Pharmacy, University Of Karachi, Karachi-75270, Pakistan (n=13) and Department
Of Physiology, University Of Karachi, Karachi-75270, Pakistan (n=12). In countries category, the highest
CPD was recorded for Morocco (n=23), followed by France (n=17), Iran (n=15), Nepal (n=13), Japan
(n=12), Tunisia (n=11), India (n=11), Thailand (n=11), Bangladesh (n=10) and South Africa (n=10).
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We can conclude that University of Karachi and Pakistan published the highest number of
publications for each year in PJPS. Similarly, the details about top authors for each year in presented in
table. 3.
3.2

Section-Two: Co-authorship network by Vosviewer
To describe the scientific collaboration between the authors, institutions and countries in a particular

research field or a journal, co-author analysis is performed. For the purpose, based on the number of
publications we selected the top authors, university and country i.e. Arayne, M.S. (n=47), University of
Karachi (n=578) and Pakistan (n=1629), respectively.

1. Arayne, M.S. collaborated with 42 authors as shown in figure. 2. Mostly he co-authored
publications with Sultana, N. (n=45), Siddiqui, F.A. (n=8), Hussain, F. (n=5), Mirza, A.Z. (n=3),
Zuberi, M.H. (n=3), Afzal, M. (n=2), Akhtar, M. (n=2), Bahadur, S.S. (n=2), Farooq, A. (n=2),
Haroon, U. (n=2), Khan, A. (n=2), Qureshi, F. (n=2), Shafi, N. (n=2), Siddiqi, T.A. (n=2) and
Zaman, M.K. (n=2).
2. In 578 publications of University, 1095 authors contributed. The data for authors with atleast five
publications are presented in figure. 3. Similarly, 77 universities published atleast two documents
with University of Karachi. While, 779 departmental addresses from twenty (n=20) countries are
noted in all documents. Departmental collaboration or interconnectivity is described in figure. 4.
Its worthy to note that University of Karachi also collaborated with other universities. The highest
collaborating documents were found for Federal Urdu University of Arts (n=86), followed by
Dow University of Health Sciences Pakistan (n=84), Jinnah Sindh Medical University (n=40),
Hamdard University (n=37), Ziauddin University (n=33), Jinnah University for Women (n=32),
Government College University Lahore (n=16), Islamia University (n=14), Baqai Medical
University (n=14), PCSIR Laboratories (n=13 ), King Saud bin Abdulaziz University for Health
Sciences (n=13) and Bahauddin Zakariya University (n=11), to name a few.
3. Pakistan collaborated with 44 countries in 1629 publications. The data is presented in figure 5.
Based on the number of publications, the highest collaboration was recoded with Saudi Arabia
(n=62), Malaysia (n=44), China (n=39), United Kingdom (n=27), United States (n=15), Australia
(n=10), Germany (n=8), Japan (n=8), United Arab Emirates (n=8), Iran (n=7), Turkey (n=7) and
Austria (n=6).
3.3

Section-Three: The top one hundred (n=100) most cited documents
It’s important to note that we presented citations clubs for all documents (n=3301) in table 4. For

example, sixty-two documents received atleast ten citations. While nine hundred and ten documents
received zero (n=0) citations. In this section we analyze the 100 most-cited articles in PJPS. The number
6

of citations received by these 100 articles ranged from 27 to 356. The cumulative total citations were
5077, while the average citations were found to be 50.77. The adjusted citation count (i.e., citation count
per year since publication) ranged from 2.1 to 32.36 (average=5.32). The title of document, year of
publication, volume, issue, page start, page end and citations for each document (total 100) is described in
supplementary table 5. Based on the number of citations, we divided all documents (n=100) in various
citations clubs. For example, one document received atleast three hundred (n=300), two documents
received atleast two hundred (n=200), three documents received atleast one hundred (n=100), seventeen
documents received atleast fifty (n=50), twenty documents received atleast forty (n=40), thirty-six
document received atleast thirty (n=30) and twenty documents received atleast twenty (n=20) citations.
3.3.1

To identify the top contributors and
Similarly, in all publications (n=100) 370 authors, 184 departments and 27 countries have

significantly contributed. The publications and citation details of all authors, departments and countries
are presented in supplementary tables 6, 7 and 8, respectively. In authors list, Arayne M.S. and Sultana N.
are the top researchers with five publications. However, the highest citations were recorded for
Ebrahimzadeh M.A. (n=529). Institutionally, the highest number documents (n=4) are published by
Department of Chemistry, University of Karachi, Karachi-75270, Pakistan, while the highest citations
were found for Pharmaceutical Sciences Research Center, School Of Pharmacy, Mazandaran University
Of Medical Sciences, 48189, Sari, Iran (n=529). In countries list, the Pakistan has contributed in highest
(n=38) number of documents. Similarly, Pakistan also has the highest citations (n=1722). Other countries
in the list with number of publications (NoP) and Ciations (C) are India (Nop=17 & C= 800), Iran
(Nop=9 & C= 855), Egypt (Nop=7 & C= 293) Saudi Arabia (Nop=5 & C= 168), Bangladesh (Nop=4 &
C= 163), Malaysia (Nop=4 & C= 125), Turkey (Nop=4 & C= 313), Thailand (Nop=3 & C= 126), Algeria
(Nop=2 & C= 72), France (Nop=2 & C= 99), Morocco (Nop=2 & C= 115), Nigeria (Nop=2 & C= 90),
United Kingdom (Nop=2& C= 105), United States (Nop=2 & C= 115), Argentina (Nop=1 & C= 32),
China (Nop=1 & C= 31), Germany (Nop=1 & C= 50), Iraq (Nop=1 & C= 27), Italy (Nop=1 & C= 27),
Japan (Nop=1 & C= 60), Jordan (Nop=1 & C= 29), Nepal (Nop=1 & C= 29), Serbia (Nop=1 & C= 29),
South Africa (Nop=1 & C= 110), Spain (Nop=1 & C= 32) and Tunisia (Nop=1 & C= 58).
3.3.2

To understand what key research themes were addressed in these publications. The
technical words in the titles of these 100 articles were manually analyzed and visualized by
VOSviewer.

The list of plant studied
In 2003, Menrad et al., reported that the global market of medicinal plants or functional foods is
US$33 billion, which enormously increased to US$168 billion (Vicentini et al., 2016). Food plants, and
spices are also easily and often commercially available through the world (8,9).
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The 100 articles involved different medicinal plants or spices. Infact the publications covered citrus
species peels and tissues, h. officinalis l. var. angustifolius, v. odorata, b. hyrcana and c. speciosum, salvia
species., berberis vulgaris, genus ajuga, black pepper, bay leaf, aniseed and coriander, garlic (allium
sativum) , tamarindus indica linn., croton zambesicus, ficus carica latex, silymarin, umbelliferae fruits,
emblica officinalis and coriandrum sativum , boesenbergia pandurata and piper sarmentosum , menthol,
tectona grandis, thespesia lampas dalz and gibs, artemisia vulgaris, propolis extract, thai medicinal plants,
glycyrrhiza glabra l. (liquorice), thespesia populnea , thymoquinone supplementation , peganum harmala
seeds, peganum harmala seeds, bunium persicum , allium sativum (garlic, some indigenous plants.,
glycyrrhiza glabra, nigella sativa ,andrographis paniculata , salacia chinensis , allium cepa, four plant
species used in folk medicine in the mediterranean basin, turkish karstic caves , grape fruit , mentha
longifolia , echinacea purpurea l., garlic (allium sativum) , prunella vulgaris l, coccinia cordifolia l. and
catharanthus roseus l., ajwa, polygonatum verticillatum, parkia speciosa hassk , thai mango seed extract,
zataria multiflora , morus alba linn. (mulberry) leaves, proniosomes , thymus capitatus from jordan,
hunteria umbellata (k. schum) and juniperus procera.
Drugs
In 100 articles, the authors also focused on various drugs. They discussed various simple, fast, and precise
methods for the separation and quantification of various drugs in bulk and pharmaceutical dosage. They
also described the formulation and evaluation of drugs delivery and release systems. Some of the studied
drugs are ibuprofen, pioglitazone and glimepiride, carvedilol, ofloxacin, thymoquinone supplementation,
sex steroid hormones, qadirvirtide, atenolol and amlodipine, metformin, captopril, proniosomes as drug
carriers, ketoprofen, tenofovir disoproxil fumarate in tablets.
Chemicals
The authors also studied various chemicals and their mechanism of action i.e., silymarin, coumarin, new
chalcones containing 1, 4 - dioxane ring system, 5-substituted-1,3,4-oxadiazole-2yl-n-(2-methoxy-5chlorophenyl)- 2-sulfanyl acetamide, and citral (a component of lemongrass).
Heavy metals
The authors also focused on understanding the toxicity of various heavy metals, and nanoparticles for
example zinc and NiO nanoparticles.
The list of their pharmacological potential
Another noticeable point is mostly the articles evaluated wider aspects of effects of the medicinal plants
and functional food. For example, the oxidative stress (OS), antimicrobial potential, nanoparticles
toxicity, antidiabetic, renal OS, biochemical characterizations, antiinflammatory, analgesic and antipyretic
activities, melastatin-8 (trpm8) ion channels, hypolipidemic, protein glycation, renal oxidative damage,
hyperlipidemic, cytotoxicity, hepatotoxicity in rats, cognitive performance, cardioprotective effects,
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hypoglycemic activity, urease, anxiolytic effects, stz-induced diabetes, antihepatotoxic activity, apoptosis,
cisplatin-induced nephrotoxicity in rats, nephro-protective, glucose induced hyperglycemic ,
antiangiogenic, immunomodulatory activity, in vivo antitumorigenic activity, nasal carriage, nonpregnant rat uterus in oestrus, zinc and endocrine system, phytotoxic and insecticidal activities were
briefly described.
Diseases or pathologies
The 100 articles also focused on numerous diseases, for example obesity, nephropathy, wound, liver
dysfunction, traumatic brain injury, hypertension, cancer, cardiovascular disease, and tardive dyskinesia.
Phytochemicals
Some important metabolites and phytochemicals are also mentioned at least in the 100 articles, including
alkaloids, essential oil flavonoids and tannin etc.…
The interconnectivity between different keywords is presented in Figure. 6.
3.4

Section-Four: Co-words analysis for all publications

To explore the main research focus or trends in publications, we performed the co-words analysis. It
analyses the frequency of co-occurrence of keywords in research documents and shows a link between the
topics to which they refer. It also describes the interaction between different fields in scientific research
(5,6).
1. Fangkun Zhao, Bei Shi, Ruixin Liu, Wenkai Zhou, Dong Shi and Jinsong Zhang. Theme trends
and knowledge structure on choroidal neovascularization: a quantitative and co-word analysis.
BMC Ophthalmology (2018) 18:86
2. Juan J. Nájera-Sánchez. A Systematic Review of Sustainable Banking through a Co-Word
Analysis. Sustainability 2020, 12, 278.
Based on the number of times of appearance Scopus provides the list of top 160 most appeared keywords.
We manually analyzed and groups them in the following four (n=4) categories.
1. General words
In this category the following words with number of times of appearance are added. These words
represent different subjects (rats, mice, humans), cell & tissues, blood, age (young, adult, aged)
and type of study. The exact words are described below.
Controlled study (n=1657), nonhuman (n=1392), male (n=1280), human (n=1260), humans
(n=1179), animals (n=1117), chemistry (n=1053), unclassified drug (n=1011), drug effect
(n=895), female (n=886), animal (n=881),

animal experiment (n=707), rat (n=586), adult

(n=569), animal model (n=455), rats (n=447), procedures (n=418), blood (n=400), middle aged
(n=383), animal tissue (n=333), mouse (n=307), rats, wistar (n=276),

mice (n=258), aged

(n=245), wistar rat (n=220), young adult (n=202), randomized controlled trial (n=194), solvent
9

(n=189), chemistry, pharmaceutical (n=187), disease models, animal (n=166), adolescent
(n=137), rabbits (n=134), animal cell (n=129), hydrogen-ion

concentration (n=127), rats,

sprague-dawley (n=127), reproducibility of results (n=107), body weight (n=103), reproducibility
(n=96), review (n=95), child (n=92), comparative study (n=323), human cell (n=144) , sprague
dawley rat (n=113), and administration, oral (n=136).
2. Plants
Those words are added in this class, which represented plants. For example, plant extracts
(n=797), isolation and purification (n=467), medicinal plant (n=366), plants, medicinal (n=268),
plant leaf (n=255), phytotherapy (n=247), plant leaves (n=182), phytochemistry (n=149), fruit
(n=115), plant medicinal product (n=107), plant root (n=104) and plant extract (n=876).
3. Drugs
Metabolism (n=615), drug effects (n=345), dose response (n=304), drug screening (n=302), doseresponse relationship, drug (n=286), time factors (n=277), drug formulation (n=215), treatment
outcome (n=211), solubility (n=197), drug efficacy (n=181), tablets (n=180), drug structure (n=
168), alcohol

(n=164), tablet

(n=161), drug stability (n=155), time factor (n=152), drug

synthesis (n=149), drug determination (n=139), herbaceous agent (n=135), hypoglycemic agents
(n=134), glucose (n=133), drug isolation (n=129), acetic acid ethyl ester (n=124), synthesis
(n=124), chloroform (n=123), ic50 (n=123), biological marker (n=122), drug solubility (n=119),
phenol derivative (n=117), oral drug administration (n=115), drug release (n=114), concentration
response (n=109), drug mechanism (n=108), chemically induced (n=106), drug evaluation,
preclinical (n=106), flavonoids (n=106), kinetics (n=103), hexane (n=102), blood glucose
(n=101), ascorbic acid (n=100), drug compounding (n=96), pharmaceutics (n=95), particle size
(n=94), chemical structure (n=92) and methanol (n=251).
4. Pharmacological Potential
The plants or various drugs were tested to understand their;
1. antimicrobial activity (n=114), microbiology (n=145), microbial sensitivity test (n=190),
antibacterial activity (n=245), anti-bacterial agents (n=369), bacillus subtilis (n=99), bacteria
(n=106), bacterial strain (n=110), escherichia coli (n=205), klebsiella pneumoniae (n=93),
pseudomonas aeruginosa (=147) and staphylococcus aureus (n=203), antifungal activity
(n=113) and antifungal agent (n=114).
2. antiinfective agent (n=440) and anti-infective agents (n=106)
3. oxidative stress (n=152), antioxidant (n=357), antioxidant activity (n=325), antioxidants
(n=318) and DPPH radical scavenging assay (n=98)
4. analgesic agent (n=94)
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5. antidiabetic agent (n=136)
6. enzyme activity (n=114) and alanine aminotransferase (n=95)
7. antiinflammatory activity (n=117), antiinflammatory agent (n=113), anti-inflammatory agents
(n=91) and
8. anti-inflammatory agents, non-steroidal (n=93).
9. antineoplastic agent (n=170)
10. genetics (n=169)
11. glucose blood level (n=136),
12. growth, development and aging (n=160)
13. Similarly, various instrumental techniques were applied to understand the biological potential
and mechanism of actions in different physiology (n=178), pathophysiology (n=131),
pathology (n=260) and histopathology (n=102). For example, Ultraviolet Spectrophotometry
(n=99), Chromatography, High Pressure Liquid (n=197), Disk Diffusion (n=103), High
Performance Liquid Chromatography (n=256), Infrared Spectroscopy (n=130) and
Spectrophotometry, Ultraviolet (n=95).
For further detail description we analyzed all research titles (n=3301). Total 9288 technical words
were noted. After a careful analysis, it was observed that the publications focused on various
chemicals/drugs or plants. The effect of different doses was studied in different biological studies and
experimental models. The major subjects studied were humans, rats, mice and rabbits etc... The authors
explored and discussed various acute and chronic pathologies. The terms used are described below. The
number of times of appearance of each word (total=9288) in represented in supplementary table 9.
Acute bacterial conjunctivitis, acute cerebral infarction, acute coronary artery syndrome, acute
coronary syndrome, acute endotoxemia, acute enteritis, acute hepatic injury, acute hypotensive activity,
acute ischemic stroke, acute kidney injury, acute leukemia, acute myocardial infarction, acute
pancreatitis, acute pulmonary embolism, acute secretory otitis medium, acute spinal injury, acute
swimming exercise, acute toxicity, acute vulvo vaginal candidiasis, adult asthmatic patient,
advanced breast cancer, advanced colorectal cancer patient, advanced glycation endproducts formation,
advanced head, advanced hepatocellular carcinoma, advanced lung adenocarcinoma, advanced lung
cancer, advanced maternal age,
allergic asthma, allergic rhinitis, alzheimer, ameliorating brittle fracture, ameliorating oxidative
stress, anaesthesia management, anemia, anesthesia, angiogenesis,
anti, anti-acetylcholinesterase, anti-allergic effect, anti alzheimers agent, anti-angiogenesis, antiarrhythmic drug, anti-arthritis, anti-avian influenza virus, anti-bacterial, anti bph capsule, anti-cancer
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activity, anti-candida, anti-cholinesterase potential, anti-coagulant, anti-dermatitis, anti-diabetic, antiestrogenic potential, anti-fatigue activity, anti-fungal, anti glycationand anti oxidation property, antihepatitis drug use effect, anti-hepatotoxic effect, anti-hiv, anti-hyperglycemic activity, anti-hypertensive
drug, anti-infectious treatment, anti -inflammation, anti-leishmanial agent, anti-lipid peroxidation, antimalarial drug, anti-metastatic potential, anti-microbial activity, anti-mutagenic activity, antimycobacterial activity, anti-myelosuppressant, anti-nociceptive agent, anti-osteoporosis drug, antioxidant, anti-parkinsonian agent, anti-proliferative, anti-pyretic activity, anti-stress, anti tb drug, antithyroid drug, anti-tubercular drug, anti-tumor potential, anti-tumorigenesis, anti-tyrosinase, anti-ulcer
activity, anti-ultraviolet activity, anti-acetylcholine esterase potential, antiacid capacity, anti-aggressive
activity, antiaging, antianxiety, anti-atherosclerotic effect, antibacterial, antibiofilm, anticancer,
anticataleptic activity, anticholinergic drug atropine, anticholinesterase activity, anticoagulant,
anticoccidial effect, anticonvulsant, antidepressant, anti-desm abunius l, antidiabetic activity, antidiarrheal
potential, antidote, anti-dyslipidemic potential, antiemetic drug, anti-epcam antibody, antiepileptic drug
valproic acid, antiepileptogenic activity, anti-erythmic effect, antifertility agent, antifouling coating,
antifungal, antiglycation, antiglycation activity, antigrowth capacity, antihepatotoxic activity, antihyperglycaemic activity, anti-inflammatory, antileishmanial, antimalarial activity, antimicrobial activity,
antineoplastic activity, anti-nephrolithiatic activity, antinociceptive activity, antioxidant, antiplatelet
aggregation agent, antiproliferative activity, antiprotozoal activity, antipyretic activity, antipyretic
potential, anti-quorum sensing, antiseptic drug, antispasmodic activity, antithrombotic drug use effect,
antitubercular activity, antitumor, antitussive compound iasp n glc, anti-tyrosinase activity, antiulcer, antiurease, anti-urolithiatic plant, antiviral activity, anxiolytic effect, apoptosis, atopic dermatitis, atrial
fibrillation,
Autoimmune thyroid disorder, autologous blood transfusion drainage, autologous bone marrow
stem cell, autophagy, autosomal recessive non syndromic hearing loss, Different bacterial strains, Biocontaining words or phrases, bipolar disorder, bipolar hemiarthroplasty replacement, blood problems,
bone, brachial plexus block, brain, breast, bronchial asthma, bronchodilator, cancer, cardiac damage, cell
apoptosis, central nerve cell damage, central nervous system, cerebrovascular disease, cervical cancer,
cognitive behavior or pathologies, colon cancer, colorectal cancer, coronary artery disease, cytoprotective
activity, dementia, dengue, depression, diabetes, dna damage, encephalitis, encephalopathy,
endometriosis, endometrium regeneration, endophthalmitis, focal cerebral infarct volume, focal cerebral
ischemia, fungal keratitis, fungal pathogen, gastric cancer, genetic, glioblastoma cell line, glioma,
gonadotrophin, gouty arthritis, hcv, heart failure, hematological, hemorrhage, hemsleya sinesis, hepatic
damage, hepatitis, hepatocellular carcinoma, hepatocytotoxicity, hepg2 cancer cell line, histology, hiv,
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human, human acute promyelocytic leukemia cell, human artificial immune system, human bite,
human bladder cancer, human blood, human body organ, human brain micro vascular endothelial cell,
human breast adenocarcinoma cell line, human breast cancer cell line, human breast carcinoma cell line,
human breast epithelial cell, human cancer cell line, human cell culture, human cheek skin sebum, human
coronary artery endothelial cell, human dectin, human drug free plasma, human erythrocyte, human
esophageal cancer cell line ec9706 proliferation, human amma globulin, human gastric cancer cell line,
human glial cell line, human gm csfr, human guanidinoacetate n methyl transferase, human interferon,
human liver, human lung adenocarcinoma tissue, human lung cancer xenograft, human lymphocyte,
human male infertility, human neuroblastoma cell, human ovarian cancer cell, human pappilomavirus,
human pathogenic microbe, human plasma, human platelet aggregation, human pulmonary artery smooth
muscle cell proliferation, human serum, human skin, human sperm function, human sperm parameter,
human sputum sample, human t cell, human triple negative breast cancer cell, human tumor cell line,
human umbilical vein endothelial cell, human urinary kalllikrein, human urine, human urine sample,
human whole blood,
Hyperlipidemia,

hypersensitivity,

hypertension,

hyperuricemia,

hypocholesterolemic,

hypocholestrolic effect, hypoglycemic, hypogonadism, hypolipidemic, hypolocomotive effect, hypoxia,
immune system, induced pathological models, infant pneumonia treatment, infantile eczema, infarct size,
infection, inflammation, influenza, intervertebral drg rf puncture way, intervertebral foramen type,
intestinal absorption, intestine ischemia reperfusion injury, intra articular & intravenous administration,
intracerebral

hemorrhage,

intravenous

analgesia,

intravenous

bolus

injection,

intravenous

dexmedetomidine, intravenous infusion, intravenous iodinated contrast medium, ischemia reperfusion,
ischemic heart disease, ischemic stroke, leishmania, leukemia cell, lumbar disc herniation, lumbar disc
protrusion, lung, metabolic disorder, metastasis, meteorological cardiovascular disease, microbial,
mitochondrial dysfunction, molecular analysis, multiple myeloma, multiple myeloma monoclonal
antibody, multiple organ toxicity, multiple sclerosis, mutagenic breeding, mutagenic effect, myocardial
dysfunction, myocardial fibrosis, myocardial infarction, myopathy, nasal carriage, nausea, neoadjuvant
chemoradiotherapy, neonatal diarrhea, neonatal hypoxia ischemia, neonatal infection, neonatal jaundice,
neonatal mortality, nephro damages, neuro modesl or pathologies, new anti-tubercular agent, obesity,
obsessive compulsive disorder, obstetric, orthodontic treatment, orthopaedic footwear, orthopaedic
surgery, osteoarthris patient, osteoarthritis, osteoporosis, osteosarcoma cell, ototoxicity, ovaries, pancreas,
pediatric problems, pediatric diarrhea, pneumonia, prostate cancer, pulmonary issues, radiochemical &
clinical evaluation, radiolabeling, radiotherapy, renal pathologies, respiratory problems, rheumatoid
arthritis, sciatic nerve injury, seizure, sepsis, serotonergic activity, skin, small cell neuroendocrine
carcinoma, spinal cord injury, trauma, tumor, vascular dementia or problems and wound.
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3.5

Section-Five: Overall ranking and conclusion
In table 5, the per year number of publications, citations, CPD, citations (for 4-years), number of

documents (for 4-years), ranking, total journals in pharmaceutical category, and % ranking is described.
The highest citescore was noted for the year 2012 (2.4), followed by 2011 (2.1) and 2013 (1.9). This
indicates a significant growth. However significant measures are needed to maintain or improve the
overall ranking and citation metrics.
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Figure 2: The co-authorship network for authors
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Figure 3: The co-authorship network for authors in different departments or institutes
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Figure 4:

The institutional co-authorship network.
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Figure 5:

The countries co-authorship network.
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Figure 6:

Interconnectivity between different keywords.
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Table 1:

Table 2:
Table 3:
Table 4:
Table 5:

The publication clubs (PC) for authors, institutes and countries.
NoA=Number of authors, NoI=Number of institutes and NoC=Number of
Countries
The citations clubs (CC) for authors, institutes and countries. NoA=Number
of authors, NoI=Number of institutes and NoC=Number of Countries
The list of top authors, university and country for each year. Ranking is
based on the total number of publications
The citation breakup or clubs for all publications (n=3301).
The number of publications, citations, CPD, citations (for 4-years), number
of documents (for 4-years), ranking, total journals in pharmaceutical
category, and % ranking. Data is for the years 2011 to 2020.
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Table 1:

PC

NoA

PC

NoI

55-60
40-50
30-40
20-29
11 to 19
10
9
8
7
6
5
4
3
2
1
Total

1
10
17
32
104
29
39
52
73
86
155
231
443
1052
5742
8066

40-45
20-29
15-19
11 to 14
5 to 10
2 to 4
1
Total

3
14
12
16
102
659
5212
6018

PC
16001620
800-820
100-199
50-99
30-39
10 to 19
5 to 8
4
3
2
1
Total

NoC
1
1
4
4
6
10
14
2
8
7
15
72

The publication clubs (PC) for authors, institutes and countries. NoA=Number of
authors, NoI=Number of institutes and NoC=Number of Countries
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Table 2:

CC

NoA

CC

NoI

500-599

3

500-550

1

400-450

1

400-420

1

300-399

5

300-360

2

200-299
100-199
51-99
30-50
11 to 29
5 to 10
1 to 4
0
Total

20
53
171
352
1266
1630
2891
1674
8066

200-250
100-199
51-99
20 to 50
11 to 19
5 to 10
1 to 4
0
Total

5
18
50
388
474
1078
2370
1631
6018

CC
75008000
20002200
18001850
15001510
900-910
800-899
600-699
500-510
400-499
200-299
100-199
51-99
20-49
11 to 15
1 to 9
0
Total

NOC
1
1
1
1
1
1
2
1
1
4
9
6
15
4
21
3
72

The citations clubs (CC) for authors, institutes and countries. NoA=Number of
authors, NoI=Number of institutes and NoC=Number of Countries
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Year
1995
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020

Table 3:

Top Authors
23 Authors have
Arayne, M.S.
Arayne, M.S. and Sultana, N.
Arayne, M.S. and Sultana, N.
Haleem, D.J.
Abo-Salem, O.M. and Anandan, R.
Sualeh, M.
Khan, R.A.
Jan, S.U. and Khan, H.
Jan, S.U.
Rizwani, G.H.
Ali, M. and Usmanghani, K.
Usmanghani, K.
Haider, S.
Ali, H., Bushra, R. and Zafar, F.
Ikram, R.
Ikram, R.

NoP
1
12
16
16
5
3
4
4
7
5
7
6
15
10
11
14
10

Top University
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi
University of Karachi

NoP
5
25
22
26
11
13
11
17
26
36
47
34
33
56
73
82
53

Top Country
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan
Pakistan

The list of top authors, university and country for each year. Ranking is based on
the total number of publications (NoP).
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NoP
7
39
30
35
23
19
19
46
76
101
136
121
157
180
222
235
169

CC
300-350
200-260
100-199
50-99
40-49
30-39
20-29
11 to 19
10
9
8
7
6
5
4
3
2
1
0
Total

Table 4:

No of Docs
1
2
3
17
20
35
128
257
62
59
99
99
113
162
184
250
365
535
910
3301

The citation breakup or clubs for all publications (n=3301).
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Year
2011
2012
2013
2014
2015
2016
2017
2018
2019

NoD

Citations

CPD

90
131
187
308
335
338
351
431
401

695
898
1162
1312
1468
1722
1962
2089
2194

7.7
6.9
6.2
4.3
4.4
5.1
5.6
4.8
5.5

Table 5:

Citations
Docs
Total
CiteScore Ranking
(4-years) (4-Years)
Journals
682
918
928
918
1179
1415
1838
1728
1489

321
376
428
716
961
1084
1207
1455
1522

2.1
2.4
1.9
1.3
1.2
1.3
1.5
1.2
1

54
52
74
87
91
93
93
95
100

169
178
179
179
181
168
178
163
169

% Ranking
(Rounded
off)
32
29
41
49
50
55
52
58
59

The number of publications, citations, CPD, citations (for 4-years), number of
documents (for 4-years), ranking, total journals in pharmaceutical category, and
% ranking. Data is for the years 2011 to 2020.
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